MetrioPharm at the ECTRIMS Conference in Berlin
The ECTRIMS Conference is the largest international conference on the treatment of multiple sclerosis. Dr. Sara Schumann and Dr. Astrid Kaiser presented preclinical data for MetrioPharm.
Photo: © Astrid Kaiser
In October you attended the ECTRIMS conference for MetrioPharm. What was your impression?
Dr. Sara Schumann: The conference is immense. This year there were more than 9000 participants who met in Berlin. One can say that this international conference is the most important forum for researchers and clinicians on multiple sclerosis (MS).
Dr. Astrid Kaiser: Many MS therapies already available today were presented. Of course, we can learn a lot from these post-marketing studies as they clearly show the advantages and disadvantages of currently available drugs.
